Publications dans les revues indexées:

• Julie P, Etienne F, Emmanuelle SC, Annie V, Pierrick K, Aude-Marie G, Ludivine K, Shahram A, Emilien D. Chronic inflammatory demyelinating polyradiculoneuropathies (CIDP) with monotruncular onset: Frequency, clinical features, electrophysiology, and evolution. Eur J Neurol. 2025 Jan;32(1):e16560. doi: 10.1111/ene.16560. Epub 2024 Nov 29.
• Berard N, Verschueren A, Fortanier E, Grapperon AM, Kouton L, Rebouh H, Gallard J, Salort-Campana E, Attarian S, Delmont E. Electrophysiological Monitoring of Asymptomatic Transthyretin Mutation Carriers. Muscle Nerve. 2025 Feb;71(2):208-215. doi: 10.1002/mus.28318. Epub 2024 Dec 12.
• Barbat du Closel L, Bonello-Palot N, Delmont E, Péréon Y, Echaniz-Laguna A, Camdessanché JP, Pakleza AN, Chanson JB, Frachet S, Magy L, Cassereau J, Cintas P, Choumert A, Devic P, Louis SL, Tard C, Solé G, Salort-Campana E, Bouhour F, Latour P, Stojkovic T, Attarian S. Phenotype-genotype correlation in X-linked Charcot-Marie-Tooth disease: A French cohort study. Eur J Neurol. 2025 Jan;32(1):e16523. doi: 10.1111/ene.16523. Epub 2024 Nov 21.
• Attarian S, Camdessanché JP, Echaniz-Laguna A, Ciumas M, Blein C, Grenier B, Solé G. Tracking myasthenia gravis severity over time: Insights from the French health insurance claims database. Eur J Neurol. 2025 Jan;32(1):e16518. doi: 10.1111/ene.16518. Epub 2024 Nov 4.
• Péréon Y, Adams D, Camdessanché JP, Chanson JB, Cintas P, Magy L, Signaté A, Solé G, Svahn J, Tard C, Hababou C, Attarian S. Diagnosis of hereditary transthyretin amyloidosis in patients with suspected chronic inflammatory demyelinating polyneuropathy unresponsive to intravenous immunoglobulins: results of a retrospective study. Orphanet J Rare Dis. 2025 Mar 1;20(1):95. doi: 10.1186/s13023-025-03589-4.
• Rebouh H, Verschueren A, Fortanier E, Grapperon AM, Kouton L, Salort-Campana E, Attarian S, Delmont E. Real-life experience with disease-modifying drugs in hereditary transthyretin amyloid polyneuropathy: A clinical and electrophysiological appraisal. Eur J Neurol. 2025 Jan;32(1):e16571. doi: 10.1111/ene.16571. Epub 2024 Nov 28.
• Staedler K, Allenbach Y, Salort-Campana E, Malfatti E, Rigolet A, Attarian S, Maues de Paula A, Léonard-Louis S, Benveniste O, Stojkovic T. Vacuolar myopathy with monoclonal gammopathy and stiffness (VAMMGAS). Eur J Neurol. 2025 Jan;32(1):e70026. doi: 10.1111/ene.70026.
• Conceição I, Berk JL, Weiler M, Kowacs PA, Dasgupta NR, Khella S, Chao CC, Attarian S, Kwoh TJ, Jung SW, Chen J, Viney NJ, Yu RZ, Gertz M, Masri A, Cruz MW, Coelho T. Correction: Switching from inotersen to eplontersen in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: analysis from NEURO-TTRansform. J Neurol. 2025 Feb 3;272(2):182. doi: 10.1007/s00415-024-12854-8.
• Grapperon AM, El Mendili MM, Maarouf A, Ranjeva JP, Guye M, Verschueren A, Attarian S, Zaaraoui W. In vivo mapping of sodium homeostasis disturbances in individual ALS patients: A brain 23Na MRI study. PLoS One. 2025 Jan 22;20(1):e0316916. doi: 10.1371/journal.pone.0316916. eCollection 2025.
• Bertini A, Reilly MM, Pisciotta C, Previtali SC, Parman Y, Battaloglu E, Laurà M, Blake J, Sacconi S, Attarian S, Stojkovic T, Bellatache M, Nouioua S, Tazir M, Cakar A, Gambardella A, Valentino P, Lewis RA, Horvath R, Zambon AA, Sabatelli M, Luigetti M, Tozza S, Manganelli F, Herrmann DN, Scherer SS, Kressin N, Ward K, Bolino A, Shy ME, Pareyson D; CMT4B Study Group; Inherited Neuropathy Consortium. Disease Progression in Charcot-Marie-Tooth Disease Type 4B (CMT4B) Associated With Mutations in Myotubularin-Related Proteins 2 and 13. Eur J Neurol. 2025 Feb;32(2):e70084. doi: 10.1111/ene.70084.
• Fortanier E, Michel CP, Hostin MA, Delmont E, Verschueren A, Guye M, Bellemare ME, Bendahan D, Attarian S. Quantitative muscle MRI combined with AI-based segmentation as a follow-up biomarker for ATTRv patients: A longitudinal pilot study. Eur J Neurol. 2025 Jan;32(1):e16574. doi: 10.1111/ene. 16574. Epub 2024 Nov 27.
• Schoser B, Attarian S, Graham R, Holdbrook F, Goldman M, Díaz-Manera J; ATB200-03 study group. Challenges in multinational rare disease clinical studies during COVID-19: regulatory assessment of cipaglucosidase alfa plus miglustat in adults with late-onset Pompe disease. J Neurol. 2025 Jan 7;272(1):103. doi: 10.1007/s00415-024-12843-x.
• Thomma RCM, Halstead SK, de Koning LC, Wiegers EEJA, Gourlay DS, Tio-Gillen AP, van Rijs W, Andersen H, Antonini G, Arends S, Attarian S, Barroso FA, Bateman KJ, Benedetti L, Van den Bergh P, Bürmann J, Busby M, Casasnovas C, Dardiotis E, Davidson A, Feasby TE, Fehmi J, Galassi G, Garcia-Sobrino T, Granit V, Gutiérrez-Gutiérrez G, Hadden RDM, Harbo T, Hartung HP, Hasan I, Holt JKL, Islam Z, Karafiath S, Katzberg HD, Kolb N, Kusunoki S, Kuwabara S, Kuwahara M, Lehmann HC, Leonhard SE, Martín-Aguilar L, Monges S, Nobile-Orazio E, Pardo J, Pereon Y, Querol L, Reisin RC, Rinaldi S, Ripellino P, Roberts RC, Scheidegger O, Shahrizaila N, Sheikh KA, Silvestri NJ, Sindrup SH, Stein B, Tan CY, Tankisi H, Visser LH, Waheed W, Huizinga R, Jacobs BC, Willison HJ; IGOS consortium. Large-scale profiling of antibody reactivity to glycolipids in patients with Guillain-Barré syndrome. Brain. 2025 Mar 17:awaf102. doi: 10.1093/brain/awaf102. Online ahead of print.
• Salort-Campana E, Attarian S. Late-onset myopathies.Curr Opin Neurol. 2024 Oct 1;37(5):523-535. doi: 10.1097/WCO.0000000000001298. Epub 2024 Jul 16.
• Attarian S. Advances in myopathy research: promising developments and challenges. Curr Opin Neurol. 2024 Oct 1;37(5):502-503. doi: 10.1097/WCO.0000000000001303. Epub 2024 Sep 5.
• Theuriet J, Masingue M, Behin A, Ferreiro A, Bassez G, Jaubert P, Tarabay O, Fer F, Pegat A, Bouhour F, Svahn J, Petiot P, Jomir L, Chauplannaz G, Cornut-Chauvinc C, Manel V, Salort-Campana E, Attarian S, Fortanier E, Verschueren A, Kouton L, Camdessanché JP, Tard C, Magot A, Péréon Y, Noury JB, Minot-Myhie MC, Perie M, Taithe F, Farhat Y, Millet AL, Cintas P, Solé G, Spinazzi M, Esselin F, Renard D, Sacconi S, Ezaru A, Malfatti E, Mallaret M, Magy L, Diab E, Merle P, Michaud M, Fournier M, Pakleza AN, Chanson JB, Lefeuvre C, Laforet P, Richard P, Sternberg D, Villar-Quiles RN, Stojkovic T, Eymard B. Congenital myasthenic syndromes in adults: clinical features, diagnosis and long-term prognosis. Brain. 2024 Nov 4;147(11):3849-3862. doi: 10.1093/brain/awae124.
• Coly M, Adams D, Attarian S, Bouhour F, Camdessanché JP, Carey G, Cauquil C, Chanson JB, Chrétien P, Créange A, Delmont E, Fargeot G, Frachet S, Gendre T, Kuntzer T, Labeyrie C, Maisonobe T, Michaud M, Moulin M, Nicolas G, Noury JB, Péréon Y, Puma A, Sole G, Taithe F, Tard C, Théaudin M, Timsit S, Venditti L, Echaniz-Laguna A. Clinical, paraclinical and outcome features of 166 patients with acute anti-GQ1b antibody syndrome. J Neurol. 2024 Aug;271(8):4982-4990. doi: 10.1007/s00415-024-12410-4. Epub 2024 May 20.
• Attarian S, Beloribi-Djefaflia S, Bernard R, Nguyen K, Cances C, Gavazza C, Echaniz-Laguna A, Espil C, Evangelista T, Feasson L, Audic F, Zagorda B, Milhe De Bovis V, Stojkovic T, Sole G, Salort-Campana E, Sacconi S. French National Protocol for diagnosis and care of facioscapulohumeral muscular dystrophy (FSHD). J Neurol. 2024 Sep;271(9):5778-5803. doi: 10.1007/s00415-024-12538-3. Epub 2024 Jul 2.
• Julie P, Etienne F, Emmanuelle SC, Annie V, Pierrick K, Aude-Marie G, Ludivine K, Shahram A, Emilien D. Chronic inflammatory demyelinating polyradiculoneuropathies (CIDP) with monotruncular onset: Frequency, clinical features, electrophysiology, and evolution. Eur J Neurol. 2025 Jan;32(1):e16560. doi: 10.1111/ene.16560. Epub 2024 Nov 29.
• Beloribi-Djefaflia S, Morales RJ, Fatehi F, Isapof A, Servais L, Leonard-Louis S, Michaud M, Verdure P, Gidaro T, Pouget J, Poinsignon V, Bonello-Palot N, Attarian S. Clinical and genetic features of patients suffering from CMT4J. J Neurol. 2024 Mar;271(3):1355-1365. doi: 10.1007/s00415-023-12076-4. Epub 2023 Nov 11.
• Attarian S, Young P, Brannagan TH, Adams D, Van Damme P, Thomas FP, Casanovas C, Kafaie J, Tard C, Walter MC, Péréon Y, Walk D, Stino A, de Visser M, Verhamme C, Amato A, Carter G, Magy L, Statland JM, Felice K. Correction to: A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot-Marie-Tooth type 1A. Orphanet J Rare Dis. 2024 Apr 1;19(1):142. doi: 10.1186/s13023-024-03110-3.
• Tard C, Bouhour F, Michaud M, Beltran S, Fournier M, Demurger F, Lagrange E, Nollet S, Sacconi S, Noury JB, Magot A, Cintas P, Renard D, Deibener-Kaminsky J, Lefeuvre C, Davion JB, Salort-Campana E, Arrassi A, Taouagh N, Spinazzi M; Pompe Study Group; Attarian S, Laforêt P. Real-life effectiveness 1 year after switching to avalglucosidase alfa in late-onset Pompe disease patients worsening on alglucosidase alfa therapy: A French cohort study. Eur J Neurol. 2024 Jul;31(7):e16292. doi: 10.1111/ene.16292. Epub 2024 Apr 8.
• Tilsley P, Moutiez A, Brodovitch A, Mendili MME, Testud B, Zaaraoui W, Verschueren A, Attarian S, Guye M, Boucraut J, Grapperon AM, Stellmann JP. Neurofilament Light Chain Levels Interact with Neurodegenerative Patterns and Motor Neuron Dysfunction in Amyotrophic Lateral Sclerosis. AJNR Am J Neuroradiol. 2024 Apr 8;45(4):494-503. doi: 10.3174/ajnr.A8154.
• Salort-Campana E, Solé G, Magot A, Tard C, Noury JB, Behin A, De La Cruz E, Boyer F, Lefeuvre C, Masingue M, Debergé L, Finet A, Brison M, Spinazzi M, Pegat A, Sacconi S, Malfatti E, Choumert A, Bellance R, Bedat-Millet AL, Feasson L, Vuillerot C, Jacquin-Piques A, Michaud M, Pereon Y, Stojkovic T, Laforêt P, Attarian S, Cintas P. Multidisciplinary team meetings in treatment of spinal muscular atrophy adult patients: a real-life observatory for innovative treatments. Orphanet J Rare Dis. 2024 Jan 24;19(1):24. doi: 10.1186/s13023-023-03008-6.
• Guérémy A, Boucraut J, Boudjarane J, Grapperon AM, Fortanier E, Farnault L, Gabert J, Vely F, Lacroix R, Kouton L, Attarian S, Delmont E. Clinical, biological, electrophysiological and therapeutic profile of patients with anti-MAG neuropathy according to MYD88L265P and CXCR4 mutations and underlying haemopathy. J Neurol. 2024 Mar;271(3):1320-1330. doi: 10.1007/s00415-023-12068-4. Epub 2023 Nov 18.
• Cruz ES, Fortanier E, Hilezian F, Maarouf A, Boutière C, Demortière S, Rico A, Delmont E, Pelletier J, Attarian S, Audoin B. Factors affecting the topography of nitrous oxide-induced neurological complications. Eur J Neurol. 2024 Jul;31(7):e16291. doi: 10.1111/ene.16291. Epub 2024 Mar 26.
• Berard N, Verschueren A, Fortanier E, Grapperon AM, Kouton L, Rebouh H, Gallard J, Salort-Campana E, Attarian S, Delmont E. Electrophysiological Monitoring of Asymptomatic Transthyretin Mutation Carriers. Muscle Nerve. 2025 Feb;71(2):208-215. doi: 10.1002/mus.28318. Epub 2024 Dec 12.
• Barbat du Closel L, Bonello-Palot N, Delmont E, Péréon Y, Echaniz-Laguna A, Camdessanché JP, Pakleza AN, Chanson JB, Frachet S, Magy L, Cassereau J, Cintas P, Choumert A, Devic P, Louis SL, Tard C, Solé G, Salort-Campana E, Bouhour F, Latour P, Stojkovic T, Attarian S. Phenotype-genotype correlation in X-linked Charcot-Marie-Tooth disease: A French cohort study. Eur J Neurol. 2025 Jan;32(1):e16523. doi: 10.1111/ene.16523. Epub 2024 Nov 21.
• Fortanier E, Hostin MA, Michel C, Delmont E, Bellemare ME, Guye M, Bendahan D, Attarian S. One-Year Longitudinal Assessment of Patients With CMT1A Using Quantitative MRI. Neurology. 2024 May 14;102(9):e209277. doi: 10.1212/WNL.0000000000209277. Epub 2024 Apr 17.
• Grapperon AM, Harlay V, Boucekine M, Devos D, Rolland AS, Desnuelle C, Delmont E, Verschueren A, Attarian S. Could the motor unit number index be an early prognostic biomarker for amyotrophic lateral sclerosis? Clin Neurophysiol. 2024 Jul;163:47-55. doi: 10.1016/j.clinph.2024.04.013. Epub 2024 Apr 26.
• Boentert M, Campana ES, Attarian S, Diaz-Manera J, Dimachkie MM, Periquet M, Thibault N, Miossec P, Zhou T, Berger KI. Post-hoc Nonparametric Analysis of Forced Vital Capacity in the COMET Trial Demonstrates Superiority of Avalglucosidase Alfa vs Alglucosidase Alfa. J Neuromuscul Dis. 2024;11(2):369-374. doi: 10.3233/JND-230175.
• Attarian S, Camdessanché JP, Echaniz-Laguna A, Ciumas M, Blein C, Grenier B, Solé G. Tracking myasthenia gravis severity over time: Insights from the French health insurance claims database.Eur J Neurol. 2025 Jan;32(1):e16518. doi: 10.1111/ene.16518. Epub 2024 Nov 4.
• Calezis C, Bonello-Palot N, Verschueren A, Azulay JP, Fortanier E, Grapperon AM, Kouton L, Gallard J, Salort-Campana E, Attarian S, Delmont E. Electrophysiological features of the peripheral neuropathy in patients with pathologic biallelic RFC1 repeat expansions. Muscle Nerve. 2024 Nov;70(5):1046-1052. doi: 10.1002/mus.28257. Epub 2024 Sep 17.
• Fargeot G, Echaniz-Laguna A, Labeyrie C, Svahn J, Camdessanché JP, Cintas P, Chanson JB, Esselin F, Piedvache C, Verstuyft C, Genestet S, Lagrange E, Magy L, Péréon Y, Sacconi S, Signate A, Nadaj-Pakleza A, Taithe F, Viala K, Tard C, Poinsignon V, Cauquil C, Attarian S, Adams D. Hereditary transthyretin amyloidosis in middle-aged and elderly patients with idiopathic polyneuropathy: a nationwide prospective study. Amyloid. 2024 Mar;31(1):62-69. doi: 10.1080/13506129. 2023. 2270661. Epub 2023 Oct 19.
• Retailleau E, Lefeuvre C, De Antonio M, Bouhour F, Tard C, Salort-Campana E, Lagrange E, Béhin A, Solé G, Noury JB, Sacconi S, Magot A, Pakleza AN, Orlikowski D, Beltran S, Spinazzi M, Cintas P, Fournier M, Bouibede F, Prigent H, Nicolas G, Taouagh N, El Guizani T, Attarian S, Arrassi A, Hamroun D, Laforêt P. Bulbar muscle impairment in patients with late onset Pompe disease: Insight from the French Pompe registry. Eur J Neurol. 2024 Oct;31(10):e16428. doi: 10.1111/ene.16428. Epub 2024 Aug 7.
• Fortanier E, Delmont E, Corazza G, Kouton L, Micallef J, Attarian S. Longitudinal follow-up and prognostic factors in nitrous oxide-induced neuropathy. J Peripher Nerv Syst. 2024 Jun;29(2):252-261. doi: 10.1111/jns.12634. Epub 2024 May 21.
• Attarian S, Campana ES, Perrier S, Afonso M, Karam P, Hai N, Laforet P. Real-world data of in-hospital administration of alglucosidase alfa in French patients with Pompe disease: results from the National Claims Database. J Neurol. 2024 Sep;271(9):5846-5852. doi: 10.1007/s00415-024-12543-6. Epub 2024 Jul 4.
• Fortanier E, Berling E, Zanin A, Le Guillou A, Micaleff J, Nicolas G, Lozeron P, Attarian S. Reply to letter on What biological markers could be used for diagnosis and monitoring of nitrous oxide abuse. Eur J Neurol. 2024 Mar;31(3):e16187. doi: 10.1111/ene.16187. Epub 2023 Dec 20.
• Fortanier E, Delmont E, Kouton L, Corazza G, Grapperon AM, Verschueren A, Attarian S, Salort-Campana E. Face to Face: deciphering facial involvement in inclusion body myositis. J Neurol. 2024 Jan;271(1):410-418. doi: 10.1007/s00415-023-11986-7. Epub 2023 Sep 23.
• Coen M, Benyamine A, Delmont E, Kaplanski G, Bouabdallah R, Xerri L, Attarian S, Serratrice J. Tell-tale immune-related neurological syndromes: Should we look for and underlying low-grade B-cell lymphoma? A retrospective study on 12 cases. Pathol Res Pract. 2024 Aug;260:155377. doi: 10.1016/j.prp.2024.155377. Epub 2024 May 31.
• Pion E, Bonne G, Atalaia A, Salort-Campana E, Gorokhova S, Attarian S, Cossée M, Krahn M. [The clinical actionability of genes: A concept for rare diseases and the first objective assessment for myopathies]. Med Sci (Paris). 2024 Nov;40 Hors-série n° 1:6-8. doi: 10.1051/medsci/2024128. Epub 2024 Nov 18.
• Rebouh H, Verschueren A, Fortanier E, Grapperon AM, Kouton L, Salort-Campana E, Attarian S, Delmont E. Real-life experience with disease-modifying drugs in hereditary transthyretin amyloid polyneuropathy: A clinical and electrophysiological appraisal. Eur J Neurol. 2025 Jan;32(1):e16571. doi: 10.1111/ene.16571. Epub 2024 Nov 28.
• Fortanier E, Hostin MA, Michel CP, Delmont E, Guye M, Bellemare ME, Attarian S, Bendahan D. Comparison of Manual vs Artificial Intelligence-Based Muscle MRI Segmentation for Evaluating Disease Progression in Patients With CMT1A. Neurology. 2024 Nov 26;103(10):e210013. doi: 10.1212/WNL.0000000000210013. Epub 2024 Oct 24.
• Fortanier E, Michel CP, Hostin MA, Delmont E, Verschueren A, Guye M, Bellemare ME, Bendahan D, Attarian S. Quantitative muscle MRI combined with AI-based segmentation as a follow-up biomarker for ATTRv patients: A longitudinal pilot study. Eur J Neurol. 2025 Jan;32(1):e16574. doi: 10.1111/ ene. 16574. Epub 2024 Nov 27.
• Attarian S. Innovation in characterizing cardiac autonomic neuropathy using supervised learning. Clin Neurophysiol. 2023 Oct;154:198-199. doi: 10.1016/j.clinph.2023.07.001. Epub 2023 Jul 13.
• Beloribi-Djefaflia S, Morales RJ, Fatehi F, Isapof A, Servais L, Leonard-Louis S, Michaud M, Verdure P, Gidaro T, Pouget J, Poinsignon V, Bonello-Palot N, Attarian S. Clinical and genetic features of patients suffering from CMT4J. J Neurol. 2024 Mar;271(3):1355-1365. doi: 10.1007/s00415-023-12076-4. Epub 2023 Nov 11.
• Guérémy A, Boucraut J, Boudjarane J, Grapperon AM, Fortanier E, Farnault L, Gabert J, Vely F, Lacroix R, Kouton L, Attarian S, Delmont E. Clinical, biological, electrophysiological and therapeutic profile of patients with anti-MAG neuropathy according to MYD88L265P and CXCR4 mutations and underlying haemopathy. J Neurol. 2024 Mar;271(3):1320-1330. doi: 10.1007/s00415-023-12068-4. Epub 2023 Nov 18.
• Lefeuvre C, De Antonio M, Bouhour F, Tard C, Salort-Campana E, Lagrange E, Behin A, Sole G, Noury JB, Sacconi S, Magot A, Nadaj-Pakleza A, Lacour A, Beltran S, Spinazzi M, Cintas P, Renard D, Michaud M, Bedat-Millet AL, Prigent H, Taouagh N, Arrassi A, Hamroun D, Attarian S, Laforêt P; for Pompe Study Group. Characteristics of Patients With Late-Onset Pompe Disease in France: Insights From the French Pompe Registry in 2022.Neurology. 2023 Aug 29;101(9):e966-e977. doi: 10.1212/WNL. 0000000000207547. Epub 2023 Jul 7.
• Pons N, Fernández-Eulate G, Pegat A, Théaudin M, Guieu R, Ripellino P, Devedjian M, Mace P, Masingue M, Léonard-Louis S, Petiot P, Roche P, Bernard E, Bouhour F, Good JM, Verschueren A, Grapperon AM, Salort E, Grosset A, Chanson JB, Nadaj-Pakleza A, Bédat-Millet AL, Choumert A, Barnier A, Hamdi G, Lesca G, Prieur F, Bruneel A, Latour P, Stojkovic T, Attarian S, Bonello-Palot N. SORD-related peripheral neuropathy in a French and Swiss cohort: Clinical features, genetic analyses, and sorbitol dosages. Eur J Neurol. 2023 Jul;30(7):2001-2011. doi: 10.1111/ene.15793. Epub 2023 Apr 4.
• Durelle C, Delmont E, Michel C, Trabelsi A, Hostin MA, Ogier A, Bendahan D, Attarian S.Quantification of muscle involvement in familial amyloid polyneuropathy using MRI. Eur J Neurol. 2023 Oct; 30(10): 3286-3295. doi: 10.1111/ene.15970. Epub 2023 Jul 23.
• Barbat du Closel L, Bonello-Palot N, Péréon Y, Echaniz-Laguna A, Camdessanche JP, Nadaj-Pakleza A, Chanson JB, Frachet S, Magy L, Cassereau J, Cintas P, Choumert A, Devic P, Leonard Louis S, Gravier Dumonceau R, Delmont E, Salort-Campana E, Bouhour F, Latour P, Stojkovic T, Attarian S. Clinical and electrophysiological characteristics of women with X-linked Charcot-Marie-Tooth disease. Eur J Neurol. 2023 Oct;30(10):3265-3276. doi: 10.1111/ene.15937. Epub 2023 Jul 5.
• Monforte M, Attarian S, Vissing J, Diaz-Manera J, Tasca G; 265th ENMC workshop participants. 265th ENMC International Workshop: Muscle imaging in Facioscapulohumeral Muscular Dystrophy (FSHD): relevance for clinical trials. 22-24 April 2022, Hoofddorp, The Netherlands. Neuromuscul Disord. 2023 Jan;33(1):65-75. doi: 10.1016/j.nmd.2022.10.005. Epub 2022 Oct 21.
• Fargeot G, Echaniz-Laguna A, Labeyrie C, Svahn J, Camdessanché JP, Cintas P, Chanson JB, Esselin F, Piedvache C, Verstuyft C, Genestet S, Lagrange E, Magy L, Péréon Y, Sacconi S, Signate A, Nadaj-Pakleza A, Taithe F, Viala K, Tard C, Poinsignon V, Cauquil C, Attarian S, Adams D. Hereditary transthyretin amyloidosis in middle-aged and elderly patients with idiopathic polyneuropathy: a nationwide prospective study. Amyloid. 2024 Mar;31(1):62-69. doi: 10.1080/13506129. 2023.2270661. Epub 2023 Oct 19.
• Fortanier E, Berling E, Zanin A, Guillou AL, Micaleff J, Nicolas G, Lozeron P, Attarian S. How to distinguish Guillain-Barré syndrome from nitrous oxide-induced neuropathy: A 2-year, multicentric, retrospective study. Eur J Neurol. 2023 Oct;30(10):3296-3306. doi: 10.1111/ene.15998. Epub 2023 Aug 7.
• Fortanier E, Berling E, Zanin A, Le Guillou A, Micaleff J, Nicolas G, Lozeron P, Attarian S. Reply to letter on What biological markers could be used for diagnosis and monitoring of nitrous oxide abuse. Eur J Neurol. 2024 Mar;31(3):e16187. doi: 10.1111/ene.16187. Epub 2023 Dec 20.
• Fortanier E, Delmont E, Kouton L, Corazza G, Grapperon AM, Verschueren A, Attarian S, Salort-Campana E. Face to Face: deciphering facial involvement in inclusion body myositis. J Neurol. 2024 Jan;271(1):410-418. doi: 10.1007/s00415-023-11986-7. Epub 2023 Sep 23.
• El Mendili MM, Verschueren A, Ranjeva JP, Guye M, Attarian S, Zaaraoui W, Grapperon AM. Association between brain and upper cervical spinal cord atrophy assessed by MRI and disease aggressiveness in amyotrophic lateral sclerosis. Neuroradiology. 2023 Sep;65(9):1395-1403. doi: 10.1007/s00234-023-03191-0. Epub 2023 Jul 17.
• Ambrosi P, Riberi A, Attarian S, Nguyen K, Guieu R, Habib G. Association of Plasma Creatinine Phosphokinase Elevation and a History of Idiopathic Cardiomyopathy in Recipients of Heart Transplant. Am J Cardiol. 2024 Feb 15;213:50-54. doi: 10.1016/j.amjcard.2023.11.070. Epub 2023 Dec 16.
• Morel V, Campana-Salort E, Boyer A, Esselin F, Walther-Louvier U, Querin G, Latour P, Lia AS, Magdelaine C, Beze-Beyrie P, Behin A, Delague V, Levy N, Stojkovic T, Attarian S, Bonello-Palot N. HINT1 neuropathy: Expanding the genotype and phenotype spectrum. Clin Genet. 2022 Nov; 102(5): 379-390. doi: 10.1111/cge.14198. Epub 2022 Aug 16.
• Bert-Marcaz C, Briantais A, Faucher B, Corazza G, Ebbo M, Attarian S, Delmont E, Fortanier E. Expanding the spectrum of VEXAS syndrome: association with acute-onset CIDP.J Neurol Neurosurg Psychiatry. 2022 Jul;93(7):797-798. doi: 10.1136/jnnp-2021-327949. Epub 2021 Dec 6.
• Cotinat M, Verschueren A, Attarian S, Viton JM, Bensoussan L. Multidisciplinary rehabilitation is relevant in severe myasthenia gravis: An observation. Ann Phys Rehabil Med. 2022 Sep;65(5):101593. doi: 10.1016/j.rehab.2021.101593. Epub 2021 Nov 19.
• Peillet C, Adams D, Attarian S, Bouhour F, Cauquil C, Cassereau J, Chanson JB, Cintas P, Creange A, Delmont E, Fargeot G, Genestet S, Gueguen A, Kaminsky AL, Kuntzer T, Labeyrie C, Michaud M, Pereon Y, Puma A, Viala K, Chretien P, Adam C, Echaniz-Laguna A. Anti-disialosyl-immunoglobulin M chronic autoimmune neuropathies: a nationwide multicenter retrospective study. Eur J Neurol. 2022 Dec;29(12):3547-3555. doi: 10.1111/ene.15523. Epub 2022 Aug 29.
• Monforte M, Attarian S, Vissing J, Diaz-Manera J, Tasca G; 265th ENMC International Workshop: Muscle imaging in Facioscapulohumeral Muscular Dystrophy (FSHD): relevance for clinical trials. 22-24 April 2022, Hoofddorp, The Netherlands. Neuromuscul Disord. 2023 Jan;33(1):65-75. doi: 10.1016/j.nmd.2022.10.005. Epub 2022 Oct 21.
• Thomas FP, Saporta MA, Attarian S, Sevilla T, Sivera R, Fabrizi GM, Genovese F, Gray AJ, Bull S, Tanesse D, Rego M, Moore A, Hollett C, Paoli X, Sénéchal T, Day L, Ouyang C, Llewellyn S, Larkin M, Boutalbi Y. Patient-Reported Symptom Burden of Charcot-Marie-Tooth Disease Type 1A: Findings From an Observational Digital Lifestyle Study. J Clin Neuromuscul Dis. 2022 Sep 1;24(1):7-17. doi: 10.1097/CND.0000000000000426. Epub 2022 Aug 19.
• Benquey T, Pion E, Cossée M, Krahn M, Stojkovic T, Perrin A, Cerino M, Molon A, Lia AS, Magdelaine C, Francou B, Guiochon-Mantel A, Malinge MC, Leguern E, Lévy N, Attarian S, Latour P, Bonello-Palot N. A National French Consensus on Gene List for the Diagnosis of Charcot-Marie-Tooth Disease and Related Disorders Using Next-Generation Sequencing. Genes (Basel). 2022 Feb 9;13(2):318. doi: 10.3390/genes13020318.
• Fortanier E, Le Corroller T, Hocquart M, Delmont E, Attarian S. Shoulder palsy following SARS-CoV-2 infection: two cases of typical Parsonage-Turner syndrome. Eur J Neurol. 2022 Aug;29(8):2548-2550. doi: 10.1111/ene.15358.
• Vecten M, Pion E, Bartoli M, Morales RJ, Sternberg D, Rendu J, Stojkovic T, Bourdain CA, Métay C, Richard I, Cerino M, Milh M, Campana-Salort E, Gorokhova S, Levy N, Latypova X, Bonne G, Biancalana V, Petit F, Molon A, Perrin A, Laforêt P, Attarian S, Krahn M, Cossée M. Objective Evaluation of Clinical Actionability for Genes Involved in Myopathies: 63 Genes with a Medical Value for Patient Care. Int J Mol Sci. 2022 Jul 31;23(15):8506. doi: 10.3390/ijms23158506.
• Cerino M, Salort-Campana E, Gorokhova S, Sevy A, Bonello-Palot N, Levy N, Attarian S, Bartoli M, Krahn M. Refining NGS diagnosis of muscular disorders. J Neurol Neurosurg Psychiatry. 2021 Feb;92(2):223-225. doi: 10.1136/jnnp-2018-319254. Epub 2020 Sep 15.
• Attarian S, Young P, Brannagan TH, Adams D, Van Damme P, Thomas FP, Casanovas C, Kafaie J, Tard C, Walter MC, Péréon Y, Walk D, Stino A, de Visser M, Verhamme C, Amato A, Carter G, Magy L, Statland JM, Felice K. A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot-Marie-Tooth type 1A. Orphanet J Rare Dis. 2021 Oct 16;16(1):433. doi: 10.1186/s13023-021-02040-8.
• Goedee HS, Attarian S, Kuntzer T, Van den Bergh P, Rajabally YA. Iatrogenic immune-mediated neuropathies: diagnostic, epidemiological and mechanistic uncertainties for causality and implications for clinical practice. J Neurol Neurosurg Psychiatry. 2021 Sep;92(9):975-982. doi: 10.1136/jnnp-2019-321663. Epub 2021 Jun 8.
• Bert-Marcaz C, Briantais A, Faucher B, Corazza G, Ebbo M, Attarian S, Delmont E, Fortanier E. Expanding the spectrum of VEXAS syndrome: association with acute-onset CIDP. J Neurol Neurosurg Psychiatry. 2022 Jul;93(7):797-798. doi: 10.1136/jnnp-2021-327949. Epub 2021 Dec 6.
• Cotinat M, Verschueren A, Attarian S, Viton JM, Bensoussan L. Multidisciplinary rehabilitation is relevant in severe myasthenia gravis: An observation. Ann Phys Rehabil Med. 2022 Sep;65(5):101593. doi: 10.1016/j.rehab.2021.101593. Epub 2021 Nov 19.
• Thomas FP, Saporta M, Attarian S, Sevilla T, Mascaró RS, Fabrizi GM, Genovese F, Gray A, Bull S, Tanesse D, Rego M, Moore A, Hollett C, Monteiro K, Paoli X, Llewellyn S, Larkin M, Boutalbi Y. Patient-reported impact of Charcot-Marie-Tooth disease: protocol for a real-world digital lifestyle study. Neurodegener Dis Manag. 2021 Feb;11(1):21-33. doi: 10.2217/nmt-2020-0044. Epub 2020 Oct 22.
• Tyberghein M, Grapperon AM, Bouquiaux O, Puma A, Attarian S, Wang FC. iMAX: A new tool for assessment of motor axon excitability. A multicenter prospective study. Clin Neurophysiol. 2022 Jan;133:20-28. doi: 10.1016/j.clinph.2021.10.004. Epub 2021 Oct 27.
• Brodovitch A, Boucraut J, Delmont E, Parlanti A, Grapperon AM, Attarian S, Verschueren A. Combination of serum and CSF neurofilament-light and neuroinflammatory biomarkers to evaluate ALS. Sci Rep. 2021 Jan 12;11(1):703. doi: 10.1038/s41598-020-80370-6.
• Solé G, Mathis S, Friedman D, Salort-Campana E, Tard C, Bouhour F, Magot A, Annane D, Clair B, Le Masson G, Soulages A, Duval F, Carla L, Violleau MH, Saulnier T, Segovia-Kueny S, Kern L, Antoine JC, Beaudonnet G, Audic F, Kremer L, Chanson JB, Nadaj-Pakleza A, Stojkovic T, Cintas P, Spinazzi M, Foubert-Samier A, Attarian S. Impact of Coronavirus Disease 2019 in a French Cohort of Myasthenia Gravis. Neurology. 2021 Apr 20;96(16):e2109-e2120. doi: 10.1212/WNL.0000000000011669. Epub 2021 Feb 10.
• Subréville M, Bonello-Palot N, Yahiaoui D, Beloribi-Djefaflia S, Fernandes S, Stojkovic T, Cassereau J, Péréon Y, Echaniz-Laguna A, Violleau MH, Soulages A, Louis SL, Masingue M, Magot A, Delmont E, Sacconi S, Adams D, Labeyrie C, Genestet S, Noury JB, Chanson JB, Lévy N, Juntas-Morales R, Tard C, Sole G, Attarian S. Genotype-phenotype correlation in French patients with myelin protein zero gene-related inherited neuropathy. Eur J Neurol. 2021 Sep;28(9):2913-2921. doi: 10.1111/ene.14948. Epub 2021 Jun 29.
• Pisella LI, Fernandes S, Solé G, Stojkovic T, Tard C, Chanson JB, Bouhour F, Salort-Campana E, Beaudonnet G, Debergé L, Duval F, Grapperon AM, Masingue M, Nadaj-Pakleza A, Péréon Y, Audic F, Behin A, Friedman D, Magot A, Noury JB, Souvannanorath S, Wahbi K, Antoine JC, Bigaut K, Camdessanché JP, Cintas P, Debs R, Espil-Taris C, Kremer L, Kuntzer T, Laforêt P, Laugel V, Mallaret M, Michaud M, Nollet S, Svahn J, Vicart S, Villar-Quiles RN, Desguerre I, Adams D, Segovia-Kueny S, Merret G, Hammouda E, Molon A, Attarian S. A multicenter cross-sectional French study of the impact of COVID-19 on neuromuscular diseases. Orphanet J Rare Dis. 2021 Oct 26;16(1):450. doi: 10.1186/s13023-021-02090-y.
• Boulay C, Delmont E, Audic F, Chabrol B, Attarian S. Motor unit number index: A potential electrophysiological biomarker for pediatric spinal muscular atrophy. Muscle Nerve. 2021 Oct;64(4):445-453. doi: 10.1002/mus.27372. Epub 2021 Sep 1.
• Grapperon AM, Verschueren A, Jouve E, Morizot-Koutlidis R, Lenglet T, Pradat PF, Salachas F, Bernard E, Delstanche S, Maertens de Noordhout A, Guy N, Danel V, Delval A, Delmont E, Rolland AS, Pulse Study Group, Jomir L, Devos D, Wang F, Attarian S. Assessing the upper motor neuron in amyotrophic lateral sclerosis using the triple stimulation technique: A multicenter prospective study. Clin Neurophysiol. 2021 Oct;132(10):2551-2557. doi: 10.1016/j.clinph.2021.08.003. Epub 2021 Aug 12.
• Salvi A, Maues De Paula A, Lévy N, Attarian S, Bartoli M. Commentary: Long-Term Exercise Reduces Formation of Tubular Aggregates and Promotes Maintenance of Ca2+ Entry Units in Aged Muscle. Front Physiol. 2021 Apr 1;12:663677. doi: 10.3389/fphys.2021.663677. eCollection 2021.
• Callot V, Massire A, Guye M, Attarian S, Verschueren A. Visualization of Gray Matter Atrophy and Anterior Corticospinal Tract Signal Hyperintensity in Amyotrophic Lateral Sclerosis Using 7T MRI. Neurology. 2021 Jun 8;96(23):1094-1095. doi: 10.1212/WNL.0000000000012072. Epub 2021 Apr 23.
• André C, Pisella L, Cottet C, Segovia-Kueny S, Molon A, Moreno-Elgard P, Bellot MC, Attarian S. [Tackling diagnostic odysseys: a priority shared by Filnemus and AFM-Téléthon]. Med Sci (Paris). 2021 Nov;37 Hors série n° 1:56-59. doi: 10.1051/medsci/2021198. Epub 2021 Dec 8.
• Attarian S, Fatehi F, Rajabally YA, Pareyson D. Hereditary neuropathy with liability to pressure palsies. J Neurol. 2020 Aug;267(8):2198-2206. doi: 10.1007/s00415-019-09319-8. Epub 2019 Apr 15.
• Cerino M, Salort-Campana E, Gorokhova S, Sevy A, Bonello-Palot N, Levy N, Attarian S, Bartoli M, Krahn M. Refining NGS diagnosis of muscular disorders. J Neurol Neurosurg Psychiatry. 2021 Feb;92(2):223-225. doi: 10.1136/jnnp-2018-319254. Epub 2020 Sep 15.
• Rajabally YA, Goedee HS, Attarian S, Hartung HP. Management challenges for chronic dysimmune neuropathies during the COVID-19 pandemic. Muscle Nerve. 2020 Jul;62(1):34-40. doi: 10.1002/mus.26896. Epub 2020 Apr 24.
• Rajabally YA, Attarian S, Delmont E. Evolving Immunologic Perspectives in Chronic Inflammatory Demyelinating Polyneuropathy. J Inflamm Res. 2020 Sep 16;13:543-549. doi: 10.2147/JIR.S224781. eCollection 2020.
• Thomas FP, Saporta M, Attarian S, Sevilla T, Mascaró RS, Fabrizi GM, Genovese F, Gray A, Bull S, Tanesse D, Rego M, Moore A, Hollett C, Monteiro K, Paoli X, Llewellyn S, Larkin M, Boutalbi Y. Patient-reported impact of Charcot-Marie-Tooth disease: protocol for a real-world digital lifestyle study. Neurodegener Dis Manag. 2021 Feb;11(1):21-33. doi: 10.2217/nmt-2020-0044. Epub 2020 Oct 22.
• Ansari B, Salort-Campana E, Ogier A, Le Troter PhD A, De Sainte Marie B, Guye M, Delmont E, Grapperon AM, Verschueren A, Bendahan D, Attarian S. Quantitative muscle MRI study of patients with sporadic inclusion body myositis. Muscle Nerve. 2020 Apr;61(4):496-503. doi: 10.1002/ mus. 26813. Epub 2020 Feb 8.
• Bas J, Ogier AC, Le Troter A, Delmont E, Leporq B, Pini L, Guye M, Parlanti A, Lefebvre MN, Bendahan D, Attarian S. Fat fraction distribution in lower limb muscles of patients with CMT1A: A quantitative MRI study. Neurology. 2020 Apr 7;94(14):e1480-e1487. doi: 10.1212/WNL.0000000000009013. Epub 2020 Jan 24.
• Rajabkhah S, Moradi K, Okhovat AA, Van Alfen N, Fathi D, Aghaghazvini L, Ashraf-Ganjouei A, Attarian S, Nafissi S, Fatehi F. Application of muscle ultrasound for the evaluation of patients with amyotrophic lateral sclerosis: An observational cross-sectional study. Muscle Nerve. 2020 Oct;62(4): 516-521. doi: 10.1002/mus.27036. Epub 2020 Aug 14.
• Delmont E, Wang F, Lefaucheur JP, Puma A, Breniere C, Beaudonnet G, Cintas P, Collin R, Fortanier E, Grapperon AM, Jomir L, Kribich H, Kouton L, Kuntzer T, Lenglet T, Magot A, Nordine T, Ochsner F, Bolloy G, Pereon Y, Salort-Campana E, Tard C, Vicino A, Verschueren A, Attarian S. Motor unit number index as an individual biomarker: Reference limits of intra-individual variability over time in healthy subjects. Clin Neurophysiol. 2020 Sep;131(9):2209-2215. doi: 10.1016/j.clinph.2020.06.019. Epub 2020 Jul 9.
• Kouton L, Boucraut J, Devaux J, Rajabally YA, Adams D, Antoine JC, Bourdain F, Brodovitch A, Camdessanché JP, Cauquil C, Ciron J, Dubard T, Echaniz-Laguna A, Grapperon AM, Juntas-Morales R, Kremer L, Kuntzer T, Labeyrie C, Lanfranco L, Léger JM, Maisonobe T, Mavroudakis N, Mecharles-Darrigol S, Merle P, Noury JB, Rouaud V, Tard C, Théaudin M, Vallat JM, Viala K, Attarian S, Delmont E. Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteins. Clin Neurophysiol. 2020 Apr;131(4):921-927. doi: 10.1016/j.clinph.2020.01.013. Epub 2020 Feb 6.
• Corazza G, Le Corroller T, Grapperon AM, Salort-Campana E, Verschueren A, Attarian S, Delmont E. Comparison of MRI and motor evoked potential with triple stimulation technique for the detection of brachial plexus abnormalities in multifocal motor neuropathy. Muscle Nerve. 2020 Mar;61(3):325-329. doi: 10.1002/mus.26773. Epub 2019 Dec 20.
• Salort-Campana E, Fatehi F, Beloribi-Djefaflia S, Roche S, Nguyen K, Bernard R, Cintas P, Solé G, Bouhour F, Ollagnon E, Sacconi S, Echaniz-Laguna A, Kuntzer T, Levy N, Magdinier F, Attarian S. Type 1 FSHD with 6-10 Repeated Units: Factors Underlying Severity in Index Cases and Disease Penetrance in Their Relatives Attention. Int J Mol Sci. 2020 Mar 23;21(6):2221. doi: 10.3390/ijms21062221.
• Delmont E, Brodovitch A, Kouton L, Allou T, Beltran S, Brisset M, Camdessanché JP, Cauquil C, Cirion J, Dubard T, Echaniz-Laguna A, Grapperon AM, Jauffret J, Juntas-Morales R, Kremer LD, Kuntzer T, Labeyrie C, Lanfranco L, Maisonobe T, Mavroudakis N, Mecharles-Darrigol S, Nicolas G, Noury JB, Perie M, Rajabally YA, Remiche G, Rouaud V, Tard C, Salort-Campana E, Verschueren A, Viala K, Wang A, Attarian S, Boucraut J. Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 sera. J Neurol. 2020 Dec;267(12):3664-3672. doi: 10.1007/s00415-020-10041-z. Epub 2020 Jul 16.
• Attarian S, Fatehi F, Rajabally YA, Pareyson D. Hereditary neuropathy with liability to pressure palsies. J Neurol. 2020 Aug;267(8):2198-2206. doi: 10.1007/s00415-019-09319-8. Epub 2019 Apr 15.
• Attarian S, Salort-Campana E. [Renewal of Filnemus: ambitious goals for 2019-2023]. Med Sci (Paris). 2019 Nov;35 Hors série n° 2:5-6. doi: 10.1051/medsci/2019238. Epub 2019 Dec 20.
• Fathi D, Nafissi S, Attarian S, Neuwirth C, Fatehi F. An overview of motor unit number index reproducibility in amyotrophic lateral sclerosis. Iran J Neurol. 2019 Jul 6;18(3):119-126.
• Magdinier F, Nguyen K, Attarian S. [Marseille welcomes the FSHD Society International Research Conference]. Med Sci (Paris). 2019 Nov;35 Hors série n° 2:55-59. doi: 10.1051/medsci/2019184. Epub 2019 Dec 20.
• Grapperon AM, Ridley B, Verschueren A, Maarouf A, Confort-Gouny S, Fortanier E, Schad L, Guye M, Ranjeva JP, Attarian S, Zaaraoui W. Quantitative Brain Sodium MRI Depicts Corticospinal Impairment in Amyotrophic Lateral Sclerosis. Radiology. 2019 Aug;292(2):422-428. doi: 10.1148/radiol. 2019182276. Epub 2019 Jun 11.
• Delmont E, Attarian S, Antoine JC, Paul S, Camdessanché JP, Grapperon AM, Brodovich A, Boucraut J. Relevance of anti-HNK1 antibodies in the management of anti-MAG neuropathies. J Neurol. 2019 Aug;266(8):1973-1979. doi: 10.1007/s00415-019-09367-0. Epub 2019 May 14.
• Verschueren A, Kianimehr G, Belingher C, Salort-Campana E, Loundou A, Grapperon AM, Attarian S. Wish to die and reasons for living among patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2019 Feb;20(1-2):68-73. doi: 10.1080/21678421. 2018. 1530265. Epub 2018 Nov 15.
• Fortanier E, Grapperon AM, Le Troter A, Verschueren A, Ridley B, Guye M, Attarian S, Ranjeva JP, Zaaraoui W. Structural Connectivity Alterations in Amyotrophic Lateral Sclerosis: A Graph Theory Based Imaging Study. Front Neurosci. 2019 Oct 2;13:1044. doi: 10.3389/fnins.2019.01044. eCollection 2019.
• Corazza G, Le Corroller T, Grapperon AM, Salort-Campana E, Verschueren A, Attarian S, Delmont E. Comparison of MRI and motor evoked potential with triple stimulation technique for the detection of brachial plexus abnormalities in multifocal motor neuropathy. Muscle Nerve. 2020 Mar;61(3):325-329. doi: 10.1002/mus.26773. Epub 2019 Dec 20.
• Franques J, Chiche L, De Paula AM, Grapperon AM, Attarian S, Pouget J, Mathis S. Characteristics of patients with vitamin B12-responsive neuropathy: a case series with systematic repeated electrophysiological assessment. Neurol Res. 2019 Jun;41(6):569-576. doi: 10.1080/01616412. 2019. 1588490. Epub 2019 Mar 19.
• Rajabally YA, Attarian S. Chronic inflammatory demyelinating polyneuropathy and malignancy: A systematic review. Muscle Nerve. 2018 Jun;57(6):875-883. doi: 10.1002/mus.26028. Epub 2017 Dec 20.
• Fatehi F, Grapperon AM, Fathi D, Delmont E, Attarian S. The utility of motor unit number index: A systematic review. Neurophysiol Clin. 2018 Oct;48(5):251-259. doi: 10.1016/j.neucli.2018.09.001. Epub 2018 Oct 2.
• Bas J, Delmont E, Fatehi F, Salort-Campana E, Verschueren A, Pouget J, Lefebvre MN, Grapperon AM, Attarian S. Motor unit number index correlates with disability in Charcot-Marie-Tooth disease. Clin Neurophysiol. 2018 Jul;129(7):1390-1396. doi: 10.1016/j.clinph.2018.04.359. Epub 2018 Apr 16.
• Verschueren A, Kianimehr G, Belingher C, Salort-Campana E, Loundou A, Grapperon AM, Attarian S. Wish to die and reasons for living among patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2019 Feb;20(1-2):68-73. doi: 10.1080/21678421. 2018. 1530265. Epub 2018 Nov 15.
• Rajabally YA, Attarian S. Chronic inflammatory demyelinating polyneuropathy and malignancy: A systematic review. Muscle Nerve. 2018 Jun;57(6):875-883. doi: 10.1002/mus.26028. Epub 2017 Dec 20.
• Fatehi F, Delmont E, Grapperon AM, Salort-Campana E, Sévy A, Verschueren A, Boucraut J, Attarian S. Motor unit number index (MUNIX) in patients with anti-MAG neuropathy. Clin Neurophysiol. 2017 Jul;128(7):1264-1269. doi: 10.1016/j.clinph.2017.04.022. Epub 2017 May 9.
• Marion S, Béhin A, Attarian S. [GNE myopathy: proven failure of sialic acid supplementation… what's next?]. Med Sci (Paris). 2017 Nov;33 Hors série n°1:55-56. doi: 10.1051/medsci/201733s111. Epub 2017 Nov 15.
• Gazzola S, Delmont E, Franques J, Boucraut J, Salort-Campana E, Verschueren A, Sagui E, Hubert AM, Pouget J, Attarian S. Predictive factors of efficacy of rituximab in patients with anti-MAG neuropathy. J Neurol Sci. 2017 Jun 15;377:144-148. doi: 10.1016/j.jns.2017.04.015. Epub 2017 Apr 12.
• Delmont E, Manso C, Querol L, Cortese A, Berardinelli A, Lozza A, Belghazi M, Malissart P, Labauge P, Taieb G, Yuki N, Illa I, Attarian S, Devaux JJ. Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy. Brain. 2017 Jul 1;140(7):1851-1858. doi: 10.1093/brain/awx124.
• Bou Ali H, Salort-Campana E, Grapperon AM, Gallard J, Franques J, Sevy A, Delmont E, Verschueren A, Pouget J, Attarian S. New strategy for improving the diagnostic sensitivity of repetitive nerve stimulation in myasthenia gravis. Muscle Nerve. 2017 Apr;55(4):532-538. doi: 10.1002/mus.25374. Epub 2017 Jan 3.
• Delmont E, Hiew FL, Cassereau J, Aubé-Nathier AC, Grapperon AM, Attarian S, Rajabally YA. Determinants of health-related quality of life in anti-MAG neuropathy: a cross-sectional multicentre European study. J Peripher Nerv Syst. 2017 Mar;22(1):27-33. doi: 10.1111/jns.12197.
• Wang W, Guedj M, Bertrand V, Foucquier J, Jouve E, Commenges D, Proust-Lima C, Murphy NP, Blin O, Magy L, Cohen D, Attarian S. A Rasch Analysis of the Charcot-Marie-Tooth Neuropathy Score (CMTNS) in a Cohort of Charcot-Marie-Tooth Type 1A Patients. PLoS One. 2017 Jan 17;12(1): e0169878. doi: 10.1371/journal.pone.0169878. eCollection 2017.
• Grimaldi S, Duprat L, Grapperon AM, Verschueren A, Delmont E, Attarian S. Global motor unit number index sum score for assessing the loss of lower motor neurons in amyotrophic lateral sclerosis. Muscle Nerve. 2017 Aug;56(2):202-206. doi: 10.1002/mus.25595. Epub 2017 Apr 1.
• Sevy A, Grapperon AM, Salort Campana E, Delmont E, Attarian S. Detection of proximal conduction blocks using a triple stimulation technique improves the early diagnosis of Guillain-Barré syndrome. Clin Neurophysiol. 2018 Jan;129(1):127-132. doi: 10.1016/j.clinph.2017.10.035. Epub 2017 Nov 11.
• Philibert M, Grapperon AM, Delmont E, Attarian S. Monitoring the short-term effect of intravenous immunoglobulins in multifocal motor neuropathy using motor unit number index. Clin Neurophysiol. 2017 Jan;128(1):235-240. doi: 10.1016/j.clinph.2016.11.012. Epub 2016 Dec 1.
• Fatehi F, Salort-Campana E, Le Troter A, Lareau-Trudel E, Bydder M, Fouré A, Guye M, Bendahan D, Attarian S. Long-term follow-up of MRI changes in thigh muscles of patients with Facioscapulohumeral dystrophy: A quantitative study. PLoS One. 2017 Aug 25;12(8):e0183825. doi: 10.1371/journal.pone.0183825. eCollection 2017.
• Leporq B, Le Troter A, Le Fur Y, Salort-Campana E, Guye M, Beuf O, Attarian S, Bendahan D. Combined quantification of fatty infiltration, T 1-relaxation times and T 2*-relaxation times in normal-appearing skeletal muscle of controls and dystrophic patients. MAGMA. 2017 Aug;30(4):407-415. doi: 10.1007/s10334-017-0616-1. Epub 2017 Mar 22.
• Rasoanandrianina H, Grapperon AM, Taso M, Girard OM, Duhamel G, Guye M, Ranjeva JP, Attarian S, Verschueren A, Callot V. Region-specific impairment of the cervical spinal cord (SC) in amyotrophic lateral sclerosis: A preliminary study using SC templates and quantitative MRI (diffusion tensor imaging/inhomogeneous magnetization transfer). NMR Biomed. 2017 Dec;30(12). doi: 10.1002/nbm.3801. Epub 2017 Sep 19.
• Rajabally YA, Adams D, Latour P, Attarian S. Hereditary and inflammatory neuropathies: a review of reported associations, mimics and misdiagnoses. J Neurol Neurosurg Psychiatry. 2016 Oct;87(10): 1051-60. doi: 10.1136/jnnp-2015-310835. Epub 2016 Mar 23.
• Ben Lassoued A, Fromonot J, Marlinge M, Basset N, Chefrour M, Vairo D, Couillaud J, Lopez L, Cuisset T, Boucraut J, Delmont E, Attarian S, Guieu R. A case of false positive cardiac troponin I in CANOMAD syndrome. Int J Cardiol. 2016 Nov 1;222:359-360. doi: 10.1016/j.ijcard.2016.07.297. Epub 2016 Aug 2.
• Sicello M, Sevy A, Borentain P, Gérolami R, Attarian S, Colson P. Evolution of hepatitis E virus-associated meningo-polyradiculoneuropathy on ribavirin. Int J Antimicrob Agents. 2016 Sep;48(3):343-5. doi: 10.1016/j.ijantimicag.2016.06.004. Epub 2016 Jul 8.
• Delmont E, Benvenutto A, Grimaldi S, Duprat L, Philibert M, Pouget J, Grapperon AM, Salort-Campana E, Sévy A, Verschueren A, Attarian S. Motor unit number index (MUNIX): Is it relevant in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)? Clin Neurophysiol. 2016 Mar;127(3):1891-4. doi: 10.1016/j.clinph.2015.12.002. Epub 2015 Dec 12.
• Philibert M, Grapperon AM, Delmont E, Attarian S. Monitoring the short-term effect of intravenous immunoglobulins in multifocal motor neuropathy using motor unit number index. Clin Neurophysiol. 2017 Jan;128(1):235-240. doi: 10.1016/j.clinph.2016.11.012. Epub 2016 Dec 1.
• Attarian S, Vallat JM, Magy L, Funalot B, Gonnaud PM, Lacour A, Péréon Y, Dubourg O, Pouget J, Micallef J, Franques J, Lefebvre MN, Ghorab K, Al-Moussawi M, Tiffreau V, Preudhomme M, Magot A, Leclair-Visonneau L, Stojkovic T, Bossi L, Lehert P, Gilbert W, Bertrand V, Mandel J, Milet A, Hajj R, Boudiaf L, Scart-Grès C, Nabirotchkin S, Guedj M, Chumakov I, Cohen D. Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A. Orphanet J Rare Dis. 2016 Jul 7;11(1):92. doi: 10.1186/s13023-016-0463-6.
• Fatehi F, Nafissi S, Urtizberea JA, Blanck-Labelle V, Lévy N, Krahn M, Dbouk MB, Attarian S. Dysferlinopathy in Iran: Clinical and genetic report. J Neurol Sci. 2015 Dec 15;359(1-2):256-9. doi: 10.1016/j.jns.2015.11.009. Epub 2015 Nov 11.
• Attarian S, Franques J, Elisabeth J, Trébuchon A, Duclos Y, Wybrecht D, Verschueren A, Salort-Campana E, Pouget J. Triple-stimulation technique improves the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve. 2015 Apr;51(4):541-8. doi: 10.1002/mus. 24352. Epub 2015 Jan 9.
• Ribot-Ciscar E, Milhe-De Bovis V, Aimonetti JM, Lapeyssonnie B, Campana-Salort E, Pouget J, Attarian S. Functional impact of vibratory proprioceptive assistance in patients with facioscapulohumeral muscular dystrophy. Muscle Nerve. 2015 Nov;52(5):780-7. doi: 10.1002/mus.24605. Epub 2015 Sep 3.
• Taieb G, Grapperon AM, Duclos Y, Franques J, Labauge P, Renard D, Yuki N, Attarian S. Proximal conduction block in the pharyngeal-cervical-brachial variant of Guillain-Barré syndrome. Muscle Nerve. 2015 Dec;52(6):1102-6. doi: 10.1002/mus.24729. Epub 2015 Jul 2.
• Verschueren A, Gallard J, Boucraut J, Honnorat J, Pouget J, Attarian S. Paraneoplastic subacute lower motor neuron syndrome associated with solid cancer. J Neurol Sci. 2015 Nov 15;358(1-2):413-6. doi: 10.1016/j.jns.2015.08.014. Epub 2015 Aug 12.
• Delmont E, Benvenutto A, Grimaldi S, Duprat L, Philibert M, Pouget J, Grapperon AM, Salort-Campana E, Sévy A, Verschueren A, Attarian S. Motor unit number index (MUNIX): Is it relevant in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)? Clin Neurophysiol. 2016 Mar;127(3):1891-4. doi: 10.1016/j.clinph.2015.12.002. Epub 2015 Dec 12.
• Gesquière-Dando A, Attarian S, Maues De Paula A, Pouget J, Salort-Campana E. Fibromyalgia-like symptoms associated with irritable bowel syndrome: A challenging diagnosis of late-onset Pompe disease. Muscle Nerve. 2015 Aug;52(2):300-4. doi: 10.1002/mus.24618. Epub 2015 Jun 18.
• Salort-Campana E, Nguyen K, Bernard R, Jouve E, Solé G, Nadaj-Pakleza A, Niederhauser J, Charles E, Ollagnon E, Bouhour F, Sacconi S, Echaniz-Laguna A, Desnuelle C, Tranchant C, Vial C, Magdinier F, Bartoli M, Arne-Bes MC, Ferrer X, Kuntzer T, Levy N, Pouget J, Attarian S. Low penetrance in facioscapulohumeral muscular dystrophy type 1 with large pathological D4Z4 alleles: a cross-sectional multicenter study.Orphanet J Rare Dis. 2015 Jan 21;10:2. doi: 10.1186/s13023-014-0218-1.